Drugs / Etodolac-lidocaine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02695381 | Mar → Aug 2016 | — | MEDRx USA, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Etodolac-lidocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02695381 ↗ |
| Route | Topical | “Etodolac-lidocaine topical patch applied one time daily” NCT02695381 ↗ |